CASIA OpenIR  > 中国科学院分子影像重点实验室
Phage Display-Derived Peptide-Based Dual-Modality Imaging Probe for Bladder Cancer Diagnosis and Resection Postinstillation: A Preclinical Study
Peng, Li1,2,3; Shang, Wenting2,4; Guo, Pengyu1,2,3; He, Kunshan2,4; Wang, Hongzhi1,3; Han, Ziyu2,4; Jiang, Hongmei2,4; Tian, Jie2,4,5; Wang, Kun2,4; Xu, Wanhai1,3
Source PublicationMOLECULAR CANCER THERAPEUTICS
ISSN1535-7163
2018-10-01
Volume17Issue:10Pages:2100-2111
Abstract

Bladder cancer is a common human malignancy. Conventional ultrasound and white-light cystoscopy are often used for bladder cancer diagnosis and resection, but insufficient specificity results in a high bladder cancer recurrence rate. New strategies for the diagnosis and resection of bladder cancer are needed. In this study, we developed a highly specific peptide-based probe for bladder cancer photoacoustic imaging (PAI) diagnosis and near-infrared (NIR)-imaging-guided resection after instillation. A bladder cancer-specific peptide (PLSWT7) was selected by in vivo phage-display technology and labeled with IRDye800CW to synthesize a bladder cancer-specific dual-modality imaging (DMI) probe (PLSWT7-DMI). The feasibility of PLSWT7-DMI-based dual-modality PAI-NIR imaging was assessed in vitro, in mouse models, and ex vivo human bladders. An air-pouch bladder cancer (APBC) model suitable for probe instillation was established to evaluate the probe-based bladder cancer PAI diagnosis and NIR-imaging-guided resection. Human bladders were used to assess whether the PLSWT7-DMI-based DMI strategy is a translatable approach for bladder cancer detection and resection. The probe exhibited excellent selectivity and specificity both in vitro and in vivo. Postinstillation of the probe, tumors <3 mm were detectable by PAI, and NIR-imaging-guided tumor resection decreased the bladder cancer recurrence rate by 90% and increased the survival in the mouse model. Additionally, ex vivo NIR imaging of human bladders indicated that PLSWT7-DMI-based imaging would potentially allow precise resection of bladder cancer in clinical settings. This PLSWT7-DMI-based DMI strategy was a translatable approach for bladder cancer diagnosis and resection and could potentially lower the bladder cancer recurrence rate. (C) 2018 AACR.

KeywordBladder Cancer
DOI10.1158/1535-7163.MCT-18-0212
WOS KeywordIN-VIVO ; CYSTOSCOPY ; AGENTS ; URINE
Indexed BySCI
Language英语
Funding ProjectNatural Science Foundation of Heilongjiang Province of China[QC2017097] ; National Natural Science Foundation of China[81270022] ; National Natural Science Foundation of China[81501540] ; National Natural Science Foundation of China[61671449] ; National Key R&D Program of China[2017YFA0205200] ; Strategic Priority Research Program from Chinese Academy of Sciences[XDB02060010] ; Beijing Municipal Science & Technology Commission[Z161100002616022] ; National Natural Science Foundation of China[61231004] ; National Natural Science Foundation of China[81227901] ; National Natural Science Foundation of China[81227901] ; National Natural Science Foundation of China[61231004] ; Beijing Municipal Science & Technology Commission[Z161100002616022] ; Strategic Priority Research Program from Chinese Academy of Sciences[XDB02060010] ; National Key R&D Program of China[2017YFA0205200] ; National Natural Science Foundation of China[61671449] ; National Natural Science Foundation of China[81501540] ; National Natural Science Foundation of China[81270022] ; Natural Science Foundation of Heilongjiang Province of China[QC2017097]
WOS Research AreaOncology
WOS SubjectOncology
WOS IDWOS:000456145700003
PublisherAMER ASSOC CANCER RESEARCH
Citation statistics
Cited Times:3[WOS]   [WOS Record]     [Related Records in WOS]
Document Type期刊论文
Identifierhttp://ir.ia.ac.cn/handle/173211/25322
Collection中国科学院分子影像重点实验室
Corresponding AuthorTian, Jie; Wang, Kun; Xu, Wanhai
Affiliation1.Harbin Med Univ, Hosp 4, Urol Surg Dept, Harbin, Heilongjiang, Peoples R China
2.Chinese Acad Sci, CAS Key Lab Mol Imaging, State Key Lab Management & Control Complex Syst, Inst Automat, Beijing, Peoples R China
3.Heilongjiang Key Lab Sci Res Urol, Harbin, Heilongjiang, Peoples R China
4.Chinese Acad Sci, Inst Automat, State Key Lab Management & Control Complex Syst, Beijing, Peoples R China
5.Beihang Univ, Beijing, Peoples R China
Corresponding Author AffilicationInstitute of Automation, Chinese Academy of Sciences
Recommended Citation
GB/T 7714
Peng, Li,Shang, Wenting,Guo, Pengyu,et al. Phage Display-Derived Peptide-Based Dual-Modality Imaging Probe for Bladder Cancer Diagnosis and Resection Postinstillation: A Preclinical Study[J]. MOLECULAR CANCER THERAPEUTICS,2018,17(10):2100-2111.
APA Peng, Li.,Shang, Wenting.,Guo, Pengyu.,He, Kunshan.,Wang, Hongzhi.,...&Xu, Wanhai.(2018).Phage Display-Derived Peptide-Based Dual-Modality Imaging Probe for Bladder Cancer Diagnosis and Resection Postinstillation: A Preclinical Study.MOLECULAR CANCER THERAPEUTICS,17(10),2100-2111.
MLA Peng, Li,et al."Phage Display-Derived Peptide-Based Dual-Modality Imaging Probe for Bladder Cancer Diagnosis and Resection Postinstillation: A Preclinical Study".MOLECULAR CANCER THERAPEUTICS 17.10(2018):2100-2111.
Files in This Item: Download All
File Name/Size DocType Version Access License
2100.full.pdf(1965KB)期刊论文作者接受稿开放获取CC BY-NC-SAView Download
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Peng, Li]'s Articles
[Shang, Wenting]'s Articles
[Guo, Pengyu]'s Articles
Baidu academic
Similar articles in Baidu academic
[Peng, Li]'s Articles
[Shang, Wenting]'s Articles
[Guo, Pengyu]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Peng, Li]'s Articles
[Shang, Wenting]'s Articles
[Guo, Pengyu]'s Articles
Terms of Use
No data!
Social Bookmark/Share
File name: 2100.full.pdf
Format: Adobe PDF
This file does not support browsing at this time
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.